Kelmen Low
About Kelmen Low
Kelmen Low is a Research Associate III at Nektar Therapeutics, with a background in medicinal and pharmaceutical chemistry. He has held various research and technical positions at prominent organizations, including Genentech and the University of California, Davis.
Current Role at Nektar Therapeutics
Kelmen Low currently serves as a Research Associate III at Nektar Therapeutics, a position he has held since 2022. He is based in San Francisco, California. In this role, he contributes to research initiatives that align with the company's focus on developing innovative therapies.
Previous Experience at Nektar Therapeutics
Prior to his current role, Kelmen Low worked at Nektar Therapeutics as a Research Associate II from 2021 to 2022. During this seven-month tenure, he was involved in various research projects, furthering his expertise in the pharmaceutical field.
Educational Background in Medicinal Chemistry
Kelmen Low earned a Master of Science in Medicinal and Pharmaceutical Chemistry from the University of California, Davis, completing his studies from 2019 to 2021. This advanced education provided him with a strong foundation in drug development and pharmaceutical sciences.
Experience as Graduate Student Researcher
From 2019 to 2021, Kelmen Low worked as a Graduate Student Researcher at the University of California, Davis. In this role, he engaged in research activities that contributed to his academic and professional development in the field of biochemistry and molecular biology.
Internship and Early Career at Genentech
Kelmen Low gained valuable experience as an intern at Genentech from 2020 to 2021. This position allowed him to apply his academic knowledge in a practical setting, enhancing his skills in the biotechnology industry. He also worked as a Manufacturing Technical Specialist at Genentech from 2017 to 2018.